FDA Advisory Committee Recommends Approval Of Brodalumab For Treatment Of Moderate-To-Severe Plaque Psoriasis

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/22/2026

1. MONRY
2. NYXH
3. TDY
4. PNR
5. ACN
6. ONON
7. IAUX
8. KKR
9. ORCL
10. LLY

Go back to FDA Advisory Committee Recommends Approval Of Brodalumab For Treatment Of Moderate-To-Severe Plaque Psoriasis
ASTRAZENECA PLC (NASDAQ: AZN) Delayed: 92.77 --0 (-0%)
Previous Close $92.77    52 Week High $35.04 
Open $92.77    52 Week Low $26.97 
Day High $92.77    P/E N/A 
Day Low $92.77    EPS $0.00 
Volume 3,338       

ASTRAZENECA PLC (NASDAQ: AZN) Delayed: 92.77 --0 (-0%)
Previous Close $92.77    52 Week High $35.04 
Open $92.77    52 Week Low $26.97 
Day High $92.77    P/E N/A 
Day Low $92.77    EPS $0.00 
Volume 3,338       

Kirin Holdings Company, Limited Sponsored ADR (AMEX: KNBWY) Delayed: 18.01 --0 (-0%)
Previous Close $18.01    52 Week High $18.64 
Open $18.01    52 Week Low $12.59 
Day High $18.01    P/E N/A 
Day Low $18.01    EPS $0.00 
Volume 1,768       

VALEANT PHARMACEUTICALS INTERNATIONAL (NYSE: VRX) Delayed: 23.40 --0 (-0%)
Previous Close $23.40    52 Week High $119.86 
Open $23.40    52 Week Low $13.77 
Day High $23.40    P/E N/A 
Day Low $23.40    EPS $0.00 
Volume 378,733       

VALEANT PHARMACEUTICALS INTERNATIONAL (NYSE: VRX) Delayed: 23.40 --0 (-0%)
Previous Close $23.40    52 Week High $119.86 
Open $23.40    52 Week Low $13.77 
Day High $23.40    P/E N/A 
Day Low $23.40    EPS $0.00 
Volume 378,733